Kneat announced that it has signed a three-year Master Services Agreement with a division of a leading global pharmaceutical company. The Agreement is effective immediately and allows the company to scale Kneat across all its business divisions and affiliates. Implementation of the software, which initially is for computer systems validation and equipment qualification at a European manufacturing site, is expected to go live in Fourth Quarter 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 CAD | -1.45% | +0.99% | +33.77% |
05-09 | Transcript : Kneat.com, inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-08 | Kneat Brief: Q1 2024 total revenue reaches $10.8 million, an increase of 35% year over year | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.77% | 259M | |
+15.15% | 332B | |
+26.25% | 219B | |
+6.75% | 148B | |
+11.33% | 56.57B | |
+19.63% | 33.46B | |
+5.92% | 30.05B | |
+127.86% | 23.02B | |
+29.32% | 21.36B | |
+51.83% | 15.08B |
- Stock Market
- Equities
- KSI Stock
- News kneat.com, inc.
- Kneat Signs Three-Year Master Services Agreement with A Division of A Global Pharmaceutical Company